The improvement of the efficiency of treatment of hypertension and obesity by individual correction of the eating behavior
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 1
Abstract
Objective — to improve the efficiency of treatment and secondary prevention of hypertension (H) and obesity by individual correction of the eating behavior (EB) against the background of standard therapy. Materials and methods. The examination involved 100 patients with H and obesity and were performed in accordance with the acting Ministry of Health (MoH) orders, with additional study on the EB peculiarities (with the DEBQ questionnaire), actual nutrition (AN with the help of questionnaire of the eating status, specifically designed for the purposes of this study), and nutrigenetic features with the use of kits for the metabolism tests («Litech» Ltd.). Patients were divided into two reciprocal groups of 50 patients each. All patients received treatment in accordance with the acting orders of the MoH of Ukraine. The 1st group received additional individual correction of EB violations, including correction of the revealed type of the EB violation, actual nutrition with account of the nutrigenetic peculiarities. The control tests were performed after 6 and 12 months of treatment. All patients underwent the measurement of standard anthropometric indices, investigation of the dynamics of the carbohydrate and lipid exchange indices, ultrasonic heart investigation with the use of diagnostic ultrasonic equipment LOGIQ 5 (N 1822SU6, 2003, USA) and Vivid3 (N 6009, 2004, USA). To establish the H degree, the 24-hours arterial pressure monitoring was performed with the use of portable device АВРМ-04 (N 2007/411066, 2007, Meditech, Hungary). Results and discussion. In the dynamics of treatment, patients of the 1st group demonstrated significant improvement of body mass index and waist circumference: they reduced in 1.2 times (p < 0.05). The number of patients’ references to doctors for correction of hypotensive therapy significantly decreased (р < 0.001), The lipid and carbohydrate metabolism indices significantly improved: TCl and LDL levels decreased in 1.5 and 1.3 times, respectively (р < 0.001), TG levels dropped down in 2.1 times (р < 0.001) and HDL levels increased in 1.4 times (р < 0.001), the НОМА-ІР indices decreased in 2.2 times (р < 0.001) in contrast to the insignificant positive dynamics in the respective indices of the patients of second group (р < 0.05). Conclusions. The administration of the individual correction of eating behavior can significantly improve the dynamics of the main clinical and biochemical parameters that affect the hypertension course, the risks of their progression and the development of complications.
Authors and Affiliations
G. D. Fadieienko, Ya. V. Nikiforova
Keywords
Related Articles
- EP ID EP582996
- DOI 10.30978/UTJ2019-1-7
- Views 94
- Downloads 0
Age-related aspects of bone tissue condition at chronic pancreatitis
The fact that chronic pancreatitis (СP) affects mostly patients of employable age is one of the important factors of its social significance. Objective — to study the state of bone tissue of patients with СP of various a...
Cardioprotective and antiatherogenic age-dependent growth differentiation factor 11 in patients with arterial hypertension in combination with obesity
Objective — to study the features of changes in the levels of growth differentiation factor 11 (FDR 11) in the blood of patients with arterial hypertension (AH) with abdominal obesity (AO) in comparison with the levels o...
The pathogenetic role of large intestine dysbiosis in the pathogenesis of the mutually burdened non-alcoholic fatty liver disease and chronic kidney disease
Objective — to establish the probable influence of the microbial state of the colon cavity (MSCC) content on the degree of steatosis and liver fibrosis in patients with non-alcoholic steatohepatitis (NASH) with obesity,...
Matrix metalloproteinase-9 and connective tissue growth factor and their role in progression of hepato-myocardial fibrosis in patients with stable coronary heart disease combined with nonalcoholic fatty liver disease
Objective — to determine the regularities of the stable coronary heart disease (CHD) progression in condition of the formation of hepatomyocardial fibrosis by serum levels of matrix metalloproteinase-9 (MMP-9) and conne...
Sarcopenia as a risk factor for chronic noncommunicable diseases
The article presents the summary of data related to the modern diagnosis of sarcopenia and management of patients with this disease. The actuality of the problem has been demonstrated, as well the difficulties of sarcope...